TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 33252564

Group type: COMPARATOR
Intervention: Ophthalmic Viscosurgical Device (OVD)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Anterior Chamber Maintainer (ACM)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Both groups (OVD and ACM)
Number of subjects: 100
Study: 35314199

Group type: EXPERIMENTAL
Intervention: Oral vitamin D3 (10,000 IU daily for 5 or 14 days) prior to debridement and PDT
Number of subjects: 58

Group type: COMPARATOR
Intervention: Standard PDT regimen without vitamin D3 pretreatment
Number of subjects: 58

Group type: COMPARATOR
Intervention: Patients with VD3 deficiency (< 31 ng/dL) in group 1
Number of subjects: 58

Group type: COMPARATOR
Intervention: Patients with normal 25-hydroxyvitamin D3 levels in group 1
Number of subjects: 58
Study: 33441705

Group type: EXPERIMENTAL
Intervention: I1 (50% of crop's water requirement)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: I2 (75% of crop's water requirement)
Number of subjects: 12

Group type: COMPARATOR
Intervention: I3 (100% of crop's water requirement, non-stress treatment)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: I4 (125% of crop's water requirement)
Number of subjects: 12
Study: 35122594

Group type: EXPERIMENTAL
Intervention: Supine Position (SP)
Number of subjects: 224

Group type: EXPERIMENTAL
Intervention: Left Lateral Position (LLP)
Number of subjects: 224

Group type: EXPERIMENTAL
Intervention: Left Lateral Position (LLP) in patients with BMI < 21 kg/m2
Number of subjects: 224

Group type: EXPERIMENTAL
Intervention: Left Lateral Position (LLP) in patients who underwent gastrectomy within three years
Number of subjects: 224

Group type: COMPARATOR
Intervention: Starting position (SP or LLP)
Number of subjects: 224
Study: 34565137

Group type: EXPERIMENTAL
Intervention: Genotype-specific regimens
Number of subjects: 795

Group type: COMPARATOR
Intervention: Pangenotypic regimens
Number of subjects: 795
Study: 35917364

Group type: EXPERIMENTAL
Intervention: Single-dose albendazole
Number of subjects: 5759

Group type: EXPERIMENTAL
Intervention: Single-dose mebendazole
Number of subjects: 5759

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5759
Study: 35513980

Group type: EXPERIMENTAL
Intervention: Loncastuximab tesirine (Lonca)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Chemoimmunotherapy (CIT)
Number of subjects: 80
Study: 35595817

Group type: EXPERIMENTAL
Intervention: Sequential paclitaxel treatment followed by fluorinated‐pyrimidine‐based adjuvant chemotherapy
Number of subjects: 556

Group type: COMPARATOR
Intervention: Monotherapy (not explicitly named in the abstract)
Number of subjects: 556
Study: 32227432

Group type: EXPERIMENTAL
Intervention: Empagliflozin 10 or 25 mg
Number of subjects: 7020

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7020
Study: 35637324

Group type: EXPERIMENTAL
Intervention: Prescription-grade Crystalline Glucosamine Sulfate (pCGS) 1500 mg/day
Number of subjects: 123

Group type: COMPARATOR
Intervention: Conventional therapy alone
Number of subjects: 123
Study: 34218304

Group type: EXPERIMENTAL
Intervention: Rupatadine (RUP) 10 mg once daily
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Montelukast (MON) 10 mg once daily
Number of subjects: 75

Group type: COMPARATOR
Intervention: Methotrexate (MTX) 15–25 mg/week plus placebo
Number of subjects: 75
Study: 32182922

Group type: EXPERIMENTAL
Intervention: Physical activity
Number of subjects: 444

Group type: EXPERIMENTAL
Intervention: Adherence to the Mediterranean diet
Number of subjects: 444
Study: 32590411

Group type: EXPERIMENTAL
Intervention: Isolated flexible frame group
Number of subjects: 12

Group type: COMPARATOR
Intervention: Krackow group
Number of subjects: 12
Study: 32382528

Group type: EXPERIMENTAL
Intervention: Individual exercise program designed based on six factors with ideal cutoff thresholds
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cutoff values determined from the elderly human database
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Physical function tests
Number of subjects: 0
Study: 34675150

Group type: EXPERIMENTAL
Intervention: Trehalose 3%/hyaluronic acid 0.15% eyedrops (Group A)
Number of subjects: 98

Group type: COMPARATOR
Intervention: Hyaluronic acid 0.15% eyedrops (Group B)
Number of subjects: 98

Group type: COMPARATOR
Intervention: No treatment (Group C)
Number of subjects: 98
Study: 34234406

Group type: COMPARATOR
Intervention: NSAID (group C)
Number of subjects: 470

Group type: EXPERIMENTAL
Intervention: Combination of NSAID and steroid eye drops (group A)
Number of subjects: 470

Group type: EXPERIMENTAL
Intervention: Drop-less surgery (peri-operative subtenon depot of dexamethasone, group E)
Number of subjects: 470

Group type: COMPARATOR
Intervention: NSAID (groups C and D)
Number of subjects: 470

Group type: EXPERIMENTAL
Intervention: Combination of NSAID and steroid eye drops (groups A and B)
Number of subjects: 470
Study: 32865057

Group type: EXPERIMENTAL
Intervention: Cold sterile water (5.74 °C)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Room temperature sterile water (26.89 °C)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Nothing instilled before dressing change
Number of subjects: 27
Study: 35167359

Group type: EXPERIMENTAL
Intervention: Yoga-Based Lifestyle Intervention (YBLI)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Standard of Care (SOC)
Number of subjects: 72
Study: 33872339

Group type: EXPERIMENTAL
Intervention: Fecal microbiota transplantation (FMT)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 8
Study: 32394663

Group type: EXPERIMENTAL
Intervention: Expertise-based pragmatic randomized controlled trial (EB-PRCT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Pragmatic randomized controlled trial (PRCT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Expertise-based randomized controlled trial (EBRCT)
Number of subjects: 0
Study: 36217115

Group type: EXPERIMENTAL
Intervention: Educational program explaining the importance of hospital cesarean rates and an interactive tool presenting hospital cesarean rates as 1-to-5-star ratings.
Number of subjects: 120621

Group type: COMPARATOR
Intervention: Educational program about hospital choice and a hospital choice tool without cesarean rate data.
Number of subjects: 120621
Study: 34004481

Group type: EXPERIMENTAL
Intervention: Delayed umbilical cord clamping (60 s after delivery)
Number of subjects: 204

Group type: COMPARATOR
Intervention: Immediate umbilical cord clamping (0‐15 s)
Number of subjects: 204

Group type: EXPERIMENTAL
Intervention: Delayed umbilical cord clamping
Number of subjects: 204

Group type: COMPARATOR
Intervention: Immediate umbilical cord clamping
Number of subjects: 204

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 204
Study: 32485438

Group type: EXPERIMENTAL
Intervention: Citrate dose
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Albumin
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Lactate
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Citrate target
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: pH
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Phosphate
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: APACHE score
Number of subjects: 103
Study: 34069379

Group type: EXPERIMENTAL
Intervention: Loss of Significance, Obsessive passion, Harmonious passion, Moral disengagement strategies
Number of subjects: 437
Study: 32070122

Group type: EXPERIMENTAL
Intervention: Group-based music intervention (n=26), delivered twice weekly for 12 weeks
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Group-based music intervention (n=26)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Control group (n=20)
Number of subjects: 46
Study: 35046193

Group type: EXPERIMENTAL
Intervention: Bur
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: OPTIDISC
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: SUPERSNAP
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: BISCO
Number of subjects: 120

Group type: COMPARATOR
Intervention: Untreated group (control)
Number of subjects: 120
Study: 32009610

Group type: EXPERIMENTAL
Intervention: PEG-lactulose
Number of subjects: 360
Study: 630982953

Group type: EXPERIMENTAL
Intervention: Rivaroxaban 2.5 mg twice daily plus aspirin 100 mg daily
Number of subjects: 27395

Group type: EXPERIMENTAL
Intervention: Rivaroxaban 5 mg twice daily alone
Number of subjects: 27395

Group type: COMPARATOR
Intervention: Aspirin 100 mg alone
Number of subjects: 27395

Group type: EXPERIMENTAL
Intervention: Rivaroxaban and aspirin
Number of subjects: 27395

Group type: COMPARATOR
Intervention: Aspirin alone
Number of subjects: 27395
Study: 616725657

Group type: EXPERIMENTAL
Intervention: Randomized Training Group (RTG; n = 50)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Periodized Group (PG; n = 11)
Number of subjects: 70
Study: 35239448

Group type: EXPERIMENTAL
Intervention: Adherent to PrEP
Number of subjects: 381

Group type: COMPARATOR
Intervention: Non-adherent to PrEP
Number of subjects: 381
Study: 34048281

Group type: EXPERIMENTAL
Intervention: Large dose of shoulder strengthening added to usual nonoperative care
Number of subjects: 200

Group type: COMPARATOR
Intervention: Usual nonoperative care
Number of subjects: 200
Study: 34138464

Group type: EXPERIMENTAL
Intervention: Telephone- and app-based questionnaire for caregivers to report changes in mental or physical health of clients, generating change-in-condition reports.
Number of subjects: 40137

Group type: COMPARATOR
Intervention: Control condition with no questionnaire.
Number of subjects: 40137
Study: 32475277

Group type: EXPERIMENTAL
Intervention: Customized regimen based on pharmacogenetic results
Number of subjects: 31

Group type: COMPARATOR
Intervention: Standard postoperative pain regimen (Control)
Number of subjects: 31
Study: 36456417

Group type: EXPERIMENTAL
Intervention: Dorsal Root Ganglion (DRG) stimulation
Number of subjects: 18

Group type: COMPARATOR
Intervention: Conventional Medical Management (CMM)
Number of subjects: 18
Study: 32041613

Group type: EXPERIMENTAL
Intervention: Combined group (FICB + DEX)
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: FICB group
Number of subjects: 119

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 119
Study: 34865316

Group type: EXPERIMENTAL
Intervention: Low surgical complexity (SCS) surgery
Number of subjects: 195

Group type: EXPERIMENTAL
Intervention: Intermediate surgical complexity (SCS) surgery
Number of subjects: 195

Group type: EXPERIMENTAL
Intervention: High surgical complexity (SCS) surgery
Number of subjects: 195

Group type: EXPERIMENTAL
Intervention: All surgical complexity (SCS) groups
Number of subjects: 195
Study: 33284821

Group type: EXPERIMENTAL
Intervention: Scabies prevalence
Number of subjects: 1318

Group type: EXPERIMENTAL
Intervention: Impetigo or infected scabies prevalence
Number of subjects: 1318

Group type: EXPERIMENTAL
Intervention: Severity of scabies cases
Number of subjects: 1318

Group type: EXPERIMENTAL
Intervention: Health-related quality of life (HRQoL) impact
Number of subjects: 1318
Study: 35639159

Group type: EXPERIMENTAL
Intervention: m-ERBT
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: b-ERBT
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: l-ERBT
Number of subjects: 180
Study: 33530530

Group type: EXPERIMENTAL
Intervention: Meal replacement‐based lifestyle intervention group (INT)
Number of subjects: 119

Group type: COMPARATOR
Intervention: Lifestyle intervention control group (CON)
Number of subjects: 119
Study: 32539815

Group type: EXPERIMENTAL
Intervention: Allogeneic hematopoietic stem cell transplantation (allo‐HSCT)
Number of subjects: 125

Group type: COMPARATOR
Intervention: Chemotherapy
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: Allogeneic hematopoietic stem cell transplantation (allo‐HSCT) with c-KIT mutation
Number of subjects: 125

Group type: COMPARATOR
Intervention: Chemotherapy with c-KIT mutation
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: Extramedullary infiltration (EI) at diagnosis
Number of subjects: 125
Study: 35475599

Group type: EXPERIMENTAL
Intervention: Values Exchange (Vx) online learning environment
Number of subjects: 91
Study: 33843820

Group type: EXPERIMENTAL
Intervention: Ayahuasca
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study: 35640916

Group type: EXPERIMENTAL
Intervention: Intensive blood pressure control
Number of subjects: 778

Group type: COMPARATOR
Intervention: Standard blood pressure control (implied control group)
Number of subjects: 778
Study: 35820939

Group type: EXPERIMENTAL
Intervention: Cognitive aids (CA) used during simulated medical emergencies
Number of subjects: 80

Group type: COMPARATOR
Intervention: No cognitive aids (CA) used during simulated medical emergencies
Number of subjects: 80
Study: 33766992

Group type: EXPERIMENTAL
Intervention: IV immunoglobulin (IVIG) 2 g/kg body weight followed by 3 additional infusions of 1 g/kg at 3-week intervals
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo (0.9% saline)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: IVIG
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 34817561

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy for Insomnia (CBT-I)
Number of subjects: 291

Group type: COMPARATOR
Intervention: Sleep Education Therapy (SET)
Number of subjects: 291

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy for Insomnia (CBT-I) with sustained remission of insomnia disorder
Number of subjects: 291
Study: 33625893

Group type: EXPERIMENTAL
Intervention: Activity monitor alone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Activity monitor plus web-based PA intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study: 32215847

Group type: EXPERIMENTAL
Intervention: Continually employed
Number of subjects: 1168

Group type: EXPERIMENTAL
Intervention: Continual unemployment
Number of subjects: 1168

Group type: EXPERIMENTAL
Intervention: Initial psychological distress
Number of subjects: 1168

Group type: EXPERIMENTAL
Intervention: Transitional employment status
Number of subjects: 1168
Study: 35714359

Group type: EXPERIMENTAL
Intervention: Bupivacaine and triamcinolone infiltration
Number of subjects: 128

Group type: COMPARATOR
Intervention: Control (no intervention)
Number of subjects: 128
Study: 33347320

Group type: EXPERIMENTAL
Intervention: Physician-delivered prevention messages (3 video messages regarding COVID-19)
Number of subjects: 14267

Group type: EXPERIMENTAL
Intervention: Messages from race/ethnicity-concordant physicians
Number of subjects: 14267
Study: 35079787

Group type: EXPERIMENTAL
Intervention: Triventricular (TriV) pacing
Number of subjects: 99

Group type: COMPARATOR
Intervention: Biventricular (BiV) pacing
Number of subjects: 99
Study: 34556520

Group type: EXPERIMENTAL
Intervention: Intranasal oxytocin (24 IU, 48 IU)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 35194158

Group type: EXPERIMENTAL
Intervention: Imatinib therapy
Number of subjects: 1364

Group type: EXPERIMENTAL
Intervention: IMTF model
Number of subjects: 1364
Study: 33977752

Group type: EXPERIMENTAL
Intervention: RCA care (observation group)
Number of subjects: 94

Group type: COMPARATOR
Intervention: Routine care (control group)
Number of subjects: 94
Study: 35285302

Group type: EXPERIMENTAL
Intervention: High-fidelity simulation experience
Number of subjects: 150
Study: 32366199

Group type: EXPERIMENTAL
Intervention: Social and financial barriers to receiving health care
Number of subjects: 393430

Group type: EXPERIMENTAL
Intervention: Race/Ethnicity
Number of subjects: 393430

Group type: EXPERIMENTAL
Intervention: Median household income
Number of subjects: 393430

Group type: EXPERIMENTAL
Intervention: Average health insurance costs
Number of subjects: 393430

Group type: EXPERIMENTAL
Intervention: Diversity index areas
Number of subjects: 393430
Study: 34389506

Group type: EXPERIMENTAL
Intervention: Mepolizumab (300 mg subcutaneously every 4 weeks)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 104
Study: 32084562

Group type: EXPERIMENTAL
Intervention: Sleeve gastrectomy
Number of subjects: 44

Group type: COMPARATOR
Intervention: Non-surgical control
Number of subjects: 44
Study: 35695687

Group type: EXPERIMENTAL
Intervention: Kovir capsule
Number of subjects: 66

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 66
Study: 34239935

Group type: EXPERIMENTAL
Intervention: Modified Recreational Volleyball (MRV)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Recreational Volleyball (RV)
Number of subjects: 34
Study: 33036674

Group type: EXPERIMENTAL
Intervention: Neurectomy
Number of subjects: 100

Group type: COMPARATOR
Intervention: Nerve Sparing
Number of subjects: 100
Study: 34875625

Group type: EXPERIMENTAL
Intervention: Sodium Bicarbonate (BIC)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Sodium Citrate (CIT)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Control condition (CON)
Number of subjects: 19
Study: 32269011

Group type: EXPERIMENTAL
Intervention: SVF-assisted fat graft
Number of subjects: 50

Group type: COMPARATOR
Intervention: Fat graft only
Number of subjects: 50
Study: 32090383

Group type: EXPERIMENTAL
Intervention: Intratesticular mepivacaine
Number of subjects: 34

Group type: COMPARATOR
Intervention: Intratesticular lidocaine
Number of subjects: 34
Study: 36039846

Group type: EXPERIMENTAL
Intervention: Intensive intervention group (nutritional education at every outpatient visit)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Control group (nutritional education once a year)
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Intensive intervention group
Number of subjects: 96
Study: 33407792

Group type: EXPERIMENTAL
Intervention: Pulmonary rehabilitation program (supervised, outpatient, twice weekly for 8 weeks)
Number of subjects: 190

Group type: COMPARATOR
Intervention: Usual care without specific instructions to exercise
Number of subjects: 190
Study: 36199946

Group type: EXPERIMENTAL
Intervention: In-room brachytherapy (IRBT)
Number of subjects: 294

Group type: COMPARATOR
Intervention: Out-room brachytherapy (ORBT)
Number of subjects: 294

Group type: EXPERIMENTAL
Intervention: Both IRBT and ORBT
Number of subjects: 294
Study: 35319625

Group type: EXPERIMENTAL
Intervention: Self‐Instructional Guide for Clinical Reasoning
Number of subjects: 51
Study: 34022445

Group type: EXPERIMENTAL
Intervention: Extraperitoneal robotic group (X-R)
Number of subjects: 203

Group type: COMPARATOR
Intervention: Extraperitoneal laparoscopic group (X-L)
Number of subjects: 203

Group type: COMPARATOR
Intervention: Transperitoneal laparoscopic group (T-L)
Number of subjects: 203

Group type: COMPARATOR
Intervention: Transperitoneal robotic group (T-R)
Number of subjects: 203
Study: 33080934

Group type: EXPERIMENTAL
Intervention: 1 cup Red Raspberry (RRB) per day for 4 weeks
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: 1 cup Red Raspberry (RRB) with 8 g Fructo-Oligosaccharides (FOS) per day for 4 weeks
Number of subjects: 35
Study: 35916800

Group type: EXPERIMENTAL
Intervention: Omega-3 (1,000 mg daily for 10 months)
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: Vitamin-D (1.5 mL daily for 10 months)
Number of subjects: 165

Group type: COMPARATOR
Intervention: Standard therapy (hydroxyurea + Ibuprofen)
Number of subjects: 165
Study: 35406087

Group type: EXPERIMENTAL
Intervention: New Zealand blackcurrant (NZBC) extract
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 12
Study: 32380463

Group type: EXPERIMENTAL
Intervention: Blood tumor mutational burden (bTMB)
Number of subjects: 424

Group type: EXPERIMENTAL
Intervention: Mutations in KEAP1
Number of subjects: 424
Study: 34420942

Group type: EXPERIMENTAL
Intervention: Aerobic exercise training (AET, n=12)
Number of subjects: 24
Study: 32679209

Group type: EXPERIMENTAL
Intervention: Intralymphatic allergen immunotherapy (ILIT) with 3 injections and a booster 1 year later
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Intralymphatic allergen immunotherapy (ILIT)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo injections
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Booster injection
Number of subjects: 36
Study: 36482103

Group type: EXPERIMENTAL
Intervention: Atezolizumab plus pegylated liposomal doxorubicin (PLD) and low-dose cyclophosphamide (atezo-chemo)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Placebo plus pegylated liposomal doxorubicin (PLD) and low-dose cyclophosphamide (placebo-chemo)
Number of subjects: 68
Study: 33141603

Group type: EXPERIMENTAL
Intervention: Ego depletion group (self-control manipulation through a written transcription task)
Number of subjects: 262

Group type: COMPARATOR
Intervention: Control group (transcribed text normally)
Number of subjects: 262
Study: 32480437

Group type: EXPERIMENTAL
Intervention: Mechanical CPT with LEGA-Kid
Number of subjects: 30

Group type: COMPARATOR
Intervention: Manual CPT
Number of subjects: 30
Study: 33694229

Group type: COMPARATOR
Intervention: Faecal microbiota transplantation (FMT)
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Rectal bacteriotherapy
Number of subjects: 96

Group type: COMPARATOR
Intervention: Vancomycin
Number of subjects: 96
Study: 33125037

Group type: EXPERIMENTAL
Intervention: NLP-CAM algorithm
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: NLP-mCAM algorithm
Number of subjects: 300
Study: 34973179

Group type: EXPERIMENTAL
Intervention: Chlorhexidine
Number of subjects: 119

Group type: COMPARATOR
Intervention: Iodine
Number of subjects: 119
Study: 33783497

Group type: EXPERIMENTAL
Intervention: Feedback with behavioural impact optimization
Number of subjects: 1401

Group type: EXPERIMENTAL
Intervention: Plain feedback
Number of subjects: 1401

Group type: COMPARATOR
Intervention: Control (no intervention)
Number of subjects: 1401

Group type: EXPERIMENTAL
Intervention: Behavioural impact group
Number of subjects: 1401
Study: 36069479

Group type: EXPERIMENTAL
Intervention: Denosumab
Number of subjects: 64

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 64
Study: 34537624

Group type: EXPERIMENTAL
Intervention: Intranasal vasopressin (AVP)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Intranasal oxytocin (OXT)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo (PLC)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Both AVP and OXT
Number of subjects: 80
Study: 34989174

Group type: EXPERIMENTAL
Intervention: NPC-21 1 mg/kg
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: NPC-21 3 mg/kg
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: NPC-21 10 mg/kg
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: NPC-21 20 mg/kg
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 34858513

Group type: EXPERIMENTAL
Intervention: Ashwagandha SR (300 mg)
Number of subjects: 130

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 130
Study: 35644107

Group type: EXPERIMENTAL
Intervention: Omega 3-6-9 supplementation
Number of subjects: 31

Group type: COMPARATOR
Intervention: Canola oil placebo
Number of subjects: 31